Skip to content

Clinical trials

Completed Phase 3 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Status: Completed Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20024
20057
20064
20074
20086
20096
20105
20114
20122
20138
20143
20155
20166
20173
20183
20197
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University14
Bayer6
Merck Sharp & Dohme LLC5
Bristol-Myers Squibb3
Hoffmann-La Roche3
National Cancer Institute (NCI)3
Assistance Publique - Hôpitaux de Paris2
Eli Lilly and Company2
Guangxi Medical University2
Hospices Civils de Lyon2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular88
Liver Neoplasms21
Neoplasms7
Stomach Neoplasms4
Bile Duct Neoplasms3
Carcinoma3
Gallbladder Neoplasms3
Uterine Cervical Neoplasms3
Anus Neoplasms2
Appendiceal Neoplasms2

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.